Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 492 * ! | Wed, 8/6/2014, 10:30 AM - 12:20 PM | CC-254B | |
| Approaches for Benefit-Risk Assessment in Clinical Development Decisionmaking — Topic Contributed Papers | |||
| Biopharmaceutical Section | |||
| Organizer(s): Weili He, Merck | |||
| Chair(s): Weili He, Merck | |||
| 10:35 AM | Using Endpoint Data to Analyze Patients Rather Than Patient Data to Analyze the Endpoints — Scott R. Evans, Harvard School of Public Health | ||
| 10:55 AM | Using Decision Analysis to Regulate Medical Devices — Xuefeng Li, FDA ; Telba Z. Irony, Center for Devices and Radiological Health ; Martin Ho, FDA | ||
| 11:15 AM | Communicating Benefit-Risk Analysis Results Using Graphics — Richard Forshee, FDA | ||
| 11:35 AM | Weight in Benefit-Risk Evaluation — Yabing Mai, Merck ; Weili He, Merck | ||
| 11:55 AM | Discussant: Jerald Schindler, Merck | ||
| 12:15 PM | Floor Discussion | ||
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.